Clinical Trials Directory

Trials / Completed

CompletedNCT00728299

The Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
384 (actual)
Sponsor
Radiant Research · Academic / Other
Sex
All
Age
45 Years – 74 Years
Healthy volunteers
Accepted

Summary

Increases in carotid artery intima-media thickness (IMT) are correlated with increased risk of stroke and myocardial infarction. The purpose of this study is to assess if pomegranate juice will retard the carotid (IMT) progression rate in men and women who have one or more existing cardiovascular risk factors (current cigarette smoking, hypertension, low HDL-cholesterol, and/or high LDL-cholesterol) upon entrance into the study.

Detailed description

Previous studies in atherosclerotic mice have shown that pomegranate supplementation reduced their macrophage oxidative stress and attenuated the development of their atherosclerosis. Further research in hypertensive humans demonstrated that pomegranate juice had an angiotensin converting enzyme (ACE)-inhibitory effect and significantly decreased systolic blood pressure. This study will use a randomized, double-blind, placebo-controlled design with eight clinic visits (one screening visit \[week -4 to -1\], one baseline visit \[week 0\], and six treatment visits \[weeks 13, 26, 38, 52, 65, and 78\]).

Conditions

Interventions

TypeNameDescription
DRUGPomWonderful Juice8 oz per day each day for 78 weeks
DRUGPlacebo juice8 oz per day for 78 weeks

Timeline

Start date
2003-09-01
Primary completion
2005-09-01
Completion
2005-09-01
First posted
2008-08-05
Last updated
2008-08-05

Source: ClinicalTrials.gov record NCT00728299. Inclusion in this directory is not an endorsement.